OverviewSuggest Edit

Cryoport delivers a complete outsourced frozen shipping solution for biological materials. This combination replaces outdated dry ice shipping, virtually eliminates the risk of cell degradation and revolutionizes deep frozen logistics. We combine the technology of liquid nitrogen dry vapor shippers with the most advanced Logistics Management Platform in the industry. The Company provides a complete outsourced solution that advances deep-frozen shipping for the life science community.
TypePublic
Founded1990
HQIrvine, US
Websitecryoport.com
Employee Ratings3.5

Latest Updates

Employees (est.) (Dec 2019)105(+15%)
Job Openings8
Revenue (FY, 2019)$33.9 M(+73%)
Share Price (Sept 2020)$45.7 (+3%)
Cybersecurity ratingBMore

Key People/Management at Cryoport

Jerrell W. Shelton

Jerrell W. Shelton

President and Chief Executive Officer, Chairman
Robert S. Stefanovich

Robert S. Stefanovich

Chief Financial Officer, Treasurer and Corporate Secretary
Mark W. Sawicki

Mark W. Sawicki

President and Chief Executive Officer
Bret Bollinger

Bret Bollinger

Chief Technology Officer
Thomas J. Heinzen

Thomas J. Heinzen

Vice President of Corporate Development
Phil Wilson

Phil Wilson

Senior Vice President of Global Operations & Supply Chain
Show more

Cryoport Office Locations

Cryoport has offices in Irvine, Brentwood, Livingston, Hoofddorp and in 1 other location
Irvine, US (HQ)
17305 Daimler St
Brentwood, US
112 Westwood Pl #350
Livingston, US
7 Industrial Pkwy #27
Hoofddorp, NL
Parellaan 18
Singapore, SG
37 Penjuru Ln, 01
Show all (5)

Cryoport Financials and Metrics

Cryoport Revenue

Embed Graph
View revenue for all periods
Cryoport's revenue was reported to be $33.94 m in FY, 2019
USD

Revenue (Q2, 2020)

9.4m

Gross profit (Q2, 2020)

5.1m

Gross profit margin (Q2, 2020), %

54.6%

Net income (Q2, 2020)

(5.8m)

EBIT (Q2, 2020)

(5.8m)

Market capitalization (22-Sept-2020)

1.8b

Closing stock price (22-Sept-2020)

45.7

Cash (30-Jun-2020)

44.3m

EV

1.8b
Cryoport's current market capitalization is $1.8 b.
USDQ1, 2012

Financial Leverage

2.1 x
Show all financial metrics

Cryoport Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

Cryoport Online and Social Media Presence

Embed Graph

Cryoport News and Updates

Chart Industries Signs Definitive Agreement to Divest Cryobiological Products Business for $320 Million to Cryoport, Inc.

ATLANTA, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (“Chart”) (NASDAQ: GTLS) today announced that it has signed a definitive agreement to divest its cryobiological products business (MVE Biological Products) within the Distribution & Storage Western Hemisphere (“D&S West”) se…

Cryoport Expands Global Supply Chain Platform by Signing Agreement to Acquire CRYOPDP

NASHVILLE, Tenn., Aug. 21, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the expansion of its global supply chain network and services by...

Cryoport to Report Third Quarter 2019 Financial Results on November 7, 2019

IRVINE, Calif., Oct. 31, 2019 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or the "Company"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, today announced that the Company will report financial results...

Cryoport and EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain

IRVINE, Calif., July 11, 2019 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) and EVERSANA™ have announced a strategic alliance to further create a fully integrated regenerative medicine supply chain solution. The alliance will be designed to leverage EVERSANA's position as...

Cryoport Announces Proposed Public Offering of Common Stock

IRVINE, Calif., June 19, 2019 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) (Nasdaq: CYRXW) ("Cryoport" or the "Company") today announced that it intends to offer shares of common stock in an underwritten public offering under an effective shelf registration statement on file with the...

Cryoport Expands into Biostorage through the Acquisition of Cryogene

IRVINE, Calif., May 14, 2019 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Company"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, today announced that it has expanded its suite of temperature-controlled solutions...
Show more

Cryoport Blogs

2019: The Year of Cryoport Milestones

New became the norm at Cryoport this year. The company announced new partnerships, new product lines, and new services seemingly every week. On top of these exciting developments were notable milestones in earnings and growth. Here, we share a quick recap of our biggest moments in 2019 –…

Avoiding Catastrophe: Addressing the Supply Chain Risks in Cell and Gene Therapy Development

There is no question that the groundbreaking treatments being developed in Cell & Gene Therapy (CGT) are fundamentally changing the way patient care is managed around the world. As with most revolutionary breakthroughs in medicine or any other industry, the supply chain is critically…

VIDEO: Complying with Critical Regulations: Cryoport’s Chain of Compliance ™

Precision medicine requires end-to-end traceability: everything from chain of custody, to chain of condition, to chain of identity. But the fragility of regenerative medicine therapies – and the need to more effectively manage risk– means that a fourth chain will soon be a regulatory req…

As Cell Therapy Approvals Speed Up, Companies Struggle with Manufacturing Demands

Early approvals of upcoming cell therapies have moved up manufacturing timelines for many firms in the biotech space. This blaze of approvals has been ignited by positive early clinical trial data, and now manufacturers are facing the substantial logistical challenges of scaling their pr…

Biostorage: A Critical Component of the Medical Research Development Process

The human genome and diseases interact in mysterious ways. Along with external factors, these interactions can affect who gets an illness, how serious it gets, at what rate, how the patient responds to treatments and the longer prognosis. 

When Failure Isn’t an Option, Trust the Supply Chain Partners with a Proven and Successful Track Record

The advances in cell and gene therapy over the last few years have been nothing less than remarkable. The amount of resources being poured into their development is reflected in the large number of new and existing companies aspiring to bring these therapies to market. These treatments, …
Show more

Cryoport Frequently Asked Questions

  • When was Cryoport founded?

    Cryoport was founded in 1990.

  • Who are Cryoport key executives?

    Cryoport's key executives are Jerrell W. Shelton, Robert S. Stefanovich and Mark W. Sawicki.

  • How many employees does Cryoport have?

    Cryoport has 105 employees.

  • What is Cryoport revenue?

    Latest Cryoport annual revenue is $33.9 m.

  • What is Cryoport revenue per employee?

    Latest Cryoport revenue per employee is $323.3 k.

  • Who are Cryoport competitors?

    Competitors of Cryoport include MegaCorp Logistics, Coyote Logistics and PeriShip.

  • Where is Cryoport headquarters?

    Cryoport headquarters is located at 17305 Daimler St, Irvine.

  • Where are Cryoport offices?

    Cryoport has offices in Irvine, Brentwood, Livingston, Hoofddorp and in 1 other location.

  • How many offices does Cryoport have?

    Cryoport has 5 offices.